Mizue Terai
- Ophthalmology top 1%
- Ocular Oncology and Treatments 28
- Immunology top 5%
- Immunotherapy and Immune Responses 15
- Oncology top 10%
- Chemokine receptors and signaling 3
- Cancer Immunotherapy and Biomarkers 3
- Hepatology top 10%
-
- Ubiquitin and proteasome pathways 5
-
- Nanoplatforms for cancer theranostics 5
-
- Corneal Surgery and Treatments 3
-
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Takami SatoMichael J. MastrangeloYutaka TamuraVitali AlexeevAndrew E. AplinSenthamil R. SelvanInna ChervonevaKen Kageyama
- Cited by
- OphthalmologyImmunologyOncology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Mizue Terai
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 73
- Ophthalmology 480
- Immunology 476
- Oncology 453
- Hepatology 54
- Biological Psychiatry 17
Countries citing papers authored by Mizue Terai
This map shows the geographic impact of Mizue Terai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mizue Terai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mizue Terai more than expected).
Fields of papers citing papers by Mizue Terai
This network shows the impact of papers produced by Mizue Terai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mizue Terai. The network helps show where Mizue Terai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mizue Terai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 37 | |
| 8 | 2018 | 69 | |
| 9 | 2017 | 54 | |
| 10 | 2017 | 35 | |
| 11 | 2015 | 53 | |
| 12 | 2015 | 23 | |
| 13 | 2015 | 59 | |
| 14 | 2015 | 33 | |
| 15 | 2011 | 18 | |
| 16 | 2011 | 30 | |
| 17 | 2011 | 200 | |
| 18 | 2009 | 18 | |
| 19 | 2003 | 9 | |
| 20 | 2001 | 174 |
About Mizue Terai
Mizue Terai is a scholar working on Ophthalmology, Immunology and Oncology, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (28 papers), Immunotherapy and Immune Responses (15 papers), Ubiquitin and proteasome pathways (5 papers), Nanoplatforms for cancer theranostics (5 papers), Corneal Surgery and Treatments (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Chemokine receptors and signaling (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Ophthalmology (480 citations), Immunology (476 citations) and Oncology (453 citations). Mizue Terai has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Takami Sato, Michael J. Mastrangelo, Yutaka Tamura, Vitali Alexeev, Andrew E. Aplin, Senthamil R. Selvan, Inna Chervoneva, Ken Kageyama, David Berd and David J. Eschelman. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.